• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Decreased cortisol response to insulin induced hypoglycaemia in asthmatics treated with inhaled fluticasone propionate.吸入丙酸氟替卡松治疗的哮喘患者对胰岛素诱导的低血糖的皮质醇反应降低。
Arch Dis Child. 2004 Nov;89(11):1055-8. doi: 10.1136/adc.2002.020560.
2
Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients.成年哮喘患者中吸入布地奈德与丙酸氟替卡松对肾上腺抑制作用的比较。
Thorax. 1996 Mar;51(3):262-6. doi: 10.1136/thx.51.3.262.
3
Effects of inhaled ciclesonide and fluticasone propionate on cortisol secretion and airway responsiveness to adenosine 5'monophosphate in asthmatic patients.吸入性环索奈德和丙酸氟替卡松对哮喘患者皮质醇分泌及气道对5'-单磷酸腺苷反应性的影响
Pulm Pharmacol Ther. 2005;18(5):328-36. doi: 10.1016/j.pupt.2005.01.004.
4
Adrenal responses to low dose synthetic ACTH (Synacthen) in children receiving high dose inhaled fluticasone.接受高剂量吸入氟替卡松治疗的儿童对低剂量合成促肾上腺皮质激素(赛可同)的肾上腺反应。
Arch Dis Child. 2006 Oct;91(10):808-13. doi: 10.1136/adc.2005.087247. Epub 2006 Mar 23.
5
Adrenal suppression, evaluated by a low dose adrenocorticotropin test, and growth in asthmatic children treated with inhaled steroids.通过低剂量促肾上腺皮质激素试验评估的肾上腺抑制情况,以及接受吸入性类固醇治疗的哮喘儿童的生长情况。
J Clin Endocrinol Metab. 2000 Feb;85(2):652-7. doi: 10.1210/jcem.85.2.6336.
6
Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma?测量支气管高反应性是否有助于在确定持续性哮喘患者的治疗方案时补充基于指南得出的临床指标?
Respir Med. 2008 May;102(5):665-73. doi: 10.1016/j.rmed.2007.12.023. Epub 2008 Mar 6.
7
[Evaluation of the effect of inhaled glucocorticosteroids by morning cortisolemia].[通过晨间血皮质醇水平评估吸入性糖皮质激素的效果]
Pneumologia. 2006 Oct-Dec;55(4):182-4.
8
Monitoring growth in asthmatic children treated with high dose inhaled glucocorticoids does not predict adrenal suppression.监测接受高剂量吸入糖皮质激素治疗的哮喘儿童的生长情况并不能预测肾上腺抑制。
Arch Dis Child. 2004 Aug;89(8):713-6. doi: 10.1136/adc.2002.022533.
9
A longitudinal assessment of the effect of inhaled fluticasone propionate therapy on adrenal function and growth in young children with asthma.吸入丙酸氟替卡松治疗对哮喘幼儿肾上腺功能和生长影响的纵向评估。
Pediatr Pulmonol. 2008 Apr;43(4):354-9. doi: 10.1002/ppul.20770.
10
[Systemic side effects of long-term treatment with low dose inhaled corticosteroids in children with asthma].[低剂量吸入性糖皮质激素长期治疗儿童哮喘的全身副作用]
Zhonghua Jie He He Hu Xi Za Zhi. 2001 Dec;24(12):740-3.

引用本文的文献

1
Long-Term Cortisol Concentration in Scalp Hair of Asthmatic Children Using Inhaled Corticosteroids: A Case-Control Study.哮喘儿童使用吸入性皮质类固醇后头皮头发中长期皮质醇浓度:病例对照研究。
Horm Res Paediatr. 2017;88(3-4):231-236. doi: 10.1159/000478526. Epub 2017 Jul 14.
2
CSACI position statement: systemic effect of inhaled corticosteroids on adrenal suppression in the management of pediatric asthma.CSACI 立场声明:吸入皮质类固醇对儿童哮喘管理中肾上腺抑制的全身作用。
Allergy Asthma Clin Immunol. 2015 Mar 14;11(1):9. doi: 10.1186/s13223-015-0075-z. eCollection 2015.
3
Adrenal suppression: A practical guide to the screening and management of this under-recognized complication of inhaled corticosteroid therapy.肾上腺抑制:吸入皮质类固醇治疗中这种未被充分认识的并发症的筛查和管理实用指南。
Allergy Asthma Clin Immunol. 2011 Aug 25;7(1):13. doi: 10.1186/1710-1492-7-13.
4
Adrenocortical suppression increases the risk of relapse in nephrotic syndrome.肾上腺皮质抑制会增加肾病综合征复发的风险。
Arch Dis Child. 2007 Jul;92(7):585-8. doi: 10.1136/adc.2006.108985. Epub 2007 Feb 6.
5
Adrenal responses to low dose synthetic ACTH (Synacthen) in children receiving high dose inhaled fluticasone.接受高剂量吸入氟替卡松治疗的儿童对低剂量合成促肾上腺皮质激素(赛可同)的肾上腺反应。
Arch Dis Child. 2006 Oct;91(10):808-13. doi: 10.1136/adc.2005.087247. Epub 2006 Mar 23.
6
Suppression of HPA axis in adults taking inhaled corticosteroids.吸入性糖皮质激素对成年患者下丘脑-垂体-肾上腺轴的抑制作用。
Thorax. 2006 Mar;61(3):272-3. doi: 10.1136/thx.2005.049643.

本文引用的文献

1
Adrenal suppression from high-dose inhaled fluticasone propionate in children with asthma.高剂量吸入丙酸氟替卡松对哮喘儿童肾上腺功能的抑制作用。
Eur Respir J. 2003 Apr;21(4):633-6. doi: 10.1183/09031936.03.00306302.
2
Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom.英国吸入性糖皮质激素相关肾上腺危象的调查。
Arch Dis Child. 2002 Dec;87(6):457-61. doi: 10.1136/adc.87.6.457.
3
Safety of the insulin tolerance test.胰岛素耐量试验的安全性。
Arch Dis Child. 2002 Oct;87(4):354-6. doi: 10.1136/adc.87.4.354.
4
Symptomatic adrenal insufficiency presenting with hypoglycaemia in children with asthma receiving high dose inhaled fluticasone propionate.在接受高剂量吸入丙酸氟替卡松治疗的哮喘儿童中,出现低血糖症状的肾上腺功能不全。
BMJ. 2002 May 4;324(7345):1081-2. doi: 10.1136/bmj.324.7345.1081.
5
Decreased morning serum cortisol levels in children with asthma treated with inhaled fluticasone propionate.吸入丙酸氟替卡松治疗的哮喘儿童晨间血清皮质醇水平降低。
Pediatrics. 2002 Feb;109(2):217-21. doi: 10.1542/peds.109.2.217.
6
Symptomatic adrenal insufficiency during inhaled corticosteroid treatment.吸入性糖皮质激素治疗期间出现的症状性肾上腺功能不全。
Arch Dis Child. 2001 Oct;85(4):330-4. doi: 10.1136/adc.85.4.330.
7
Dose response with fluticasone propionate on adrenocortical activity and recovery of basal and stimulated responses after stopping treatment.丙酸氟替卡松对肾上腺皮质活性的剂量反应以及停药后基础反应和刺激反应的恢复情况。
Clin Endocrinol (Oxf). 1999 Mar;50(3):329-35. doi: 10.1046/j.1365-2265.1999.00652.x.
8
Inhaled fluticasone propionate: a review of its therapeutic efficacy at dosages < or = 500 microg/day in adults and adolescents with mild to moderate asthma.吸入丙酸氟替卡松:对成人及青少年轻至中度哮喘患者每日剂量≤500微克时的治疗效果综述。
Drugs. 1999 May;57(5):769-803. doi: 10.2165/00003495-199957050-00016.
9
Effects of fluticasone propionate, triamcinolone acetonide, prednisone, and placebo on the hypothalamic-pituitary-adrenal axis.丙酸氟替卡松、曲安奈德、泼尼松及安慰剂对下丘脑-垂体-肾上腺轴的影响。
J Allergy Clin Immunol. 1999 Apr;103(4):622-9. doi: 10.1016/s0091-6749(99)70234-4.
10
Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group.以气道高反应性作为长期治疗的额外指导时哮喘的临床控制和组织病理学结果。AMPUL研究组
Am J Respir Crit Care Med. 1999 Apr;159(4 Pt 1):1043-51. doi: 10.1164/ajrccm.159.4.9806052.

吸入丙酸氟替卡松治疗的哮喘患者对胰岛素诱导的低血糖的皮质醇反应降低。

Decreased cortisol response to insulin induced hypoglycaemia in asthmatics treated with inhaled fluticasone propionate.

作者信息

Mahachoklertwattana P, Sudkronrayudh K, Direkwattanachai C, Choubtum L, Okascharoen C

机构信息

Department of Pediatrics, Ramathibodi Hospital, Faculty of Medicine, Mahidol University, Bangkok, Thailand 10400.

出版信息

Arch Dis Child. 2004 Nov;89(11):1055-8. doi: 10.1136/adc.2002.020560.

DOI:10.1136/adc.2002.020560
PMID:15499064
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1719701/
Abstract

AIMS

To assess adrenal function in asthmatic children treated with inhaled fluticasone propionate for up to 16 weeks.

METHODS

Children with asthma and bronchial hyperresponsiveness to inhaled methacholine were treated with inhaled fluticasone 250-750 microg/day via Volumatic spacer. The insulin tolerance test (ITT) was performed to assess adrenal function.

RESULTS

Eighteen asthmatic patients (10 boys, 8 girls), aged 7-17 years received inhaled fluticasone therapy at a median dose of 477 microg/m2 per day for 5-16 weeks. Adrenal suppression, defined as 60 minute serum cortisol less than 500 nmol/l, was found in 9 of 18 children. Following the ITT, the median basal and 60 minute serum cortisol concentrations of the suppressed group were 135.0 and 350.0 nmol/l, respectively; the corresponding values for the unsuppressed group were 242.2 and 564.7 nmol/l. Repeat ITT in the suppressed group 2-3 months after discontinuation of fluticasone revealed that all patients had a 60 minute serum cortisol greater than 500 nmol/l.

CONCLUSION

After therapy for asthma with inhaled fluticasone at approximately 500 microg daily for up to 16 weeks, half the children had evidence of adrenal suppression.

摘要

目的

评估接受吸入丙酸氟替卡松治疗长达16周的哮喘儿童的肾上腺功能。

方法

对患有哮喘且对吸入乙酰甲胆碱有支气管高反应性的儿童,通过Volumatic储雾罐给予250 - 750微克/天的吸入丙酸氟替卡松治疗。进行胰岛素耐量试验(ITT)以评估肾上腺功能。

结果

18例年龄在7 - 17岁的哮喘患者(10名男孩,8名女孩)接受了吸入丙酸氟替卡松治疗,中位剂量为每天477微克/平方米,持续5 - 16周。在18名儿童中,有9名出现肾上腺抑制,定义为60分钟时血清皮质醇低于500纳摩尔/升。ITT后,受抑制组的中位基础血清皮质醇浓度和60分钟时血清皮质醇浓度分别为135.0和350.0纳摩尔/升;未受抑制组的相应值为242.2和564.7纳摩尔/升。在停用氟替卡松2 - 3个月后,对受抑制组进行重复ITT,结果显示所有患者60分钟时血清皮质醇均大于500纳摩尔/升。

结论

在以约500微克/天的剂量吸入丙酸氟替卡松治疗哮喘长达16周后,半数儿童有肾上腺抑制的证据。